Tag: Survival
Many More Lives Could Have Been Saved With Convalescent COVID-19 Plasma
Per a recent study, ideal CCP use could have saved 234,869 lives and prevented 1,136,133 hospitalizations
Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
Longer progression-free survival seen with nivolumab + doxorubicin, vinblastine, and dacarbazine (AVD) versus brentuximab vedotin + AVD
Cancer Survival Rates Rose for Young Adults After Affordable Care Act
Benefits seen for young adults eligible for dependent care expansion
Fear of Cancer Recurrence Common Decades After Surviving Childhood Cancer
Fear also tied to worse mental and physical health
Large Difference in Survival Seen for Preemies Born at 25 Versus 22 Weeks
Survival ranges from 24.9 percent at 22 weeks to 82.0 percent at 25 weeks; survival without severe complications varies from 6.3 to 43.2 percent
Study: Five-Year Survival for Face Transplant Is 85 Percent
Overall, 50 face transplants have been performed worldwide
Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLC
Findings seen in patients previously treated with platinum-based chemotherapy and immunotherapy whose tumors highly expressed CEACAM5
Perioperative Nivolumab Beneficial for Resectable NSCLC
Perioperative nivolumab showed event-free survival benefit from time of surgery compared with neoadjuvant nivolumab
Stroke Survivors More Likely to Have Abnormal Sleep Duration
Stroke survivors more likely to report more than eight hours, less than seven hours, and less than six hours/night
Caseload Strain Linked to Patient Survival During Delta Wave of COVID-19
One in five COVID-19 deaths due to strain-attributable mortality; findings were consistent across hospital types
